This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Ulcerating skin lesions from blastic plasmacytoid dendritic cell neoplasm responding to low-dose radiotherapy—a case report and literature review
Strahlentherapie und Onkologie Open Access 29 January 2024
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Herling M, Jones D . CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells. Am J Clin Pathol 2007; 127: 687–700.
Petrella T, Comeau MR, Maynadie M, Couillault G, De Muret A, Maliszewski CR et al. Agranular CD4+ CD56+ hematodermic neoplasm’ (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 2002; 26: 852–862.
Dalle S, Beylot-Barry M, Bagot M, Lipsker D, Machet L, Joly P et al. Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br J Dermatol 2010; 162: 74–79.
Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M et al. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol 2005; 123: 662–675.
Feuillard J, Jacob MC, Valensi F, Maynadie M, Gressin R, Chaperot L et al. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood 2002; 99: 1556–1563.
Bekkenk MW, Jansen PM, Meijer CJ, Willemze R . CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol 2004; 15: 1097–1108.
Leitenberger JJ, Berthelot CN, Polder KD, Pro B, McLaughlin P, Jones D et al. CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate. J Am Acad Dermatol 2008; 58: 480–484.
Seaton ED, Szydlo RM, Kanfer E, Apperley JF, Russell-Jones R . Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response. Blood 2003; 102: 1217–1223.
Miller JD, Kirkland EB, Domingo DS, Scull H, Jekutis B, Dallas M et al. Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma. Photodermatol Photoimmunol Photomed 2007; 23: 163–171.
Foss FM, Gorgun G, Miller KB . Extracorporeal photopheresis in chronic graft-versus-host disease. Bone Marrow Transplant 2002; 29: 719–725.
Berger CL, Xu AL, Hanlon D, Lee C, Schechner J, Glusac E et al. Induction of human tumor-loaded dendritic cells. Int J Cancer 2001; 91: 438–447.
Narita M, Kuroha T, Watanabe N, Hashimoto S, Tsuchiyama J, Tochiki N et al. Plasmacytoid dendritic cell leukemia with potent antigen-presenting ability. Acta Haematol 2008; 120: 91–99.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Dohm, A., Hasenkamp, J., Bertsch, H. et al. Progression of a CD4+/CD56+ blastic plasmacytoid DC neoplasm after initiation of extracorporeal photopheresis in an allogeneic transplant recipient. Bone Marrow Transplant 46, 899–900 (2011). https://doi.org/10.1038/bmt.2010.196
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2010.196
This article is cited by
-
Ulcerating skin lesions from blastic plasmacytoid dendritic cell neoplasm responding to low-dose radiotherapy—a case report and literature review
Strahlentherapie und Onkologie (2024)